CXCL17 is a mucosal chemokine elevated in idiopathic pulmonary fibrosis that exhibits broad antimicrobial activity

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 6399-6406

  Burkhardt, Amanda M ^a   Tai, Kenneth P ^b   Flores Guiterrez, Juan P ^c   Vilches Cisneros, Natalia ^c   Kamdar, Karishma ^a,b   Barbosa Quintana, Oralia ^c   Valle Rios, Ricardo ^a   Hevezi, Peter A ^a   Zuñiga, Joaquin ^d   Selman, Moises ^d   Ouellette, André J ^b   Zlotnik, Albert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^d INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CXCL17 CHEMOKINE; UNCLASSIFIED DRUG;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BRONCHUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEFENSE MECHANISM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LUNG FIBROSIS; LUNG LAVAGE; MALE; MUCOSA; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION;

AGED; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES, CXC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY MUCOSA;

EID: 84862626656     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102903     Document Type: Article

References (47)

1. Zlotnik, A., O. Yoshie, and H. Nomiyama. 2006. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol. 7: 243.
2. Van Der Meer, P., S. H. Goldberg, K. M. Fung, L. R. Sharer, F. González- Scarano, and E. Lavi. 2001. Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain. J. Neuropathol. Exp. Neurol. 60: 25-32. (Pubitemid 32097003)
3. Li, M., J. Yu, Y. Li, D. Li, D. Yan, and Q. Ruan. 2010. CXCR4+ progenitors derived from bone mesenchymal stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Cell. Reprogram. 12: 405-415.
4. Kunkel, E. J., J. J. Campbell, G. Haraldsen, J. Pan, J. Boisvert, A. I. Roberts, E. C. Ebert, M. A. Vierra, S. B. Goodman, M. C. Genovese, et al. 2000. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192: 761-768.
5. Onai, N.,M. Kitabatake, Y. Y. Zhang, H. Ishikawa, S. Ishikawa, and K.Matsushima.2002. Pivotal role of CCL25 (TECK)-CCR9 in the formation of gut cryptopatches and consequent appearance of intestinal intraepithelial T lymphocytes. Int. Immunol. 14: 687-694. (Pubitemid 34822818)
6. Morteau, O., C. Gerard, B. Lu, S. Ghiran, M. Rits, Y. Fujiwara, Y. Law, K. Distelhorst, E. M. Nielsen, E. D. Hill, et al. 2008. An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J. Immunol. 181: 6309-6315.
7. Wilson, E., and E. C. Butcher. 2004. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J. Exp. Med. 200: 805-809. (Pubitemid 39299466)
8. Hieshima, K., H. Ohtani, M. Shibano, D. Izawa, T. Nakayama, Y. Kawasaki, F. Shiba, M. Shiota, F. Katou, T. Saito, and O. Yoshie. 2003. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J. Immunol. 170: 1452-1461. (Pubitemid 36139514)
9. Roth, R. B., P. Hevezi, J. Lee, D. Willhite, S. M. Lechner, A. C. Foster, and A. Zlotnik. 2006. Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics 7: 67-80.
10. Hevezi, P., B. D. Moyer, M. Lu, N. Gao, E. White, F. Echeverri, D. Kalabat, H. Soto, B. Laita, C. Li, et al. 2009. Genome-wide analysis of gene expression in primate taste buds reveals links to diverse processes. PLoS ONE 4: e6395.
11. Lee, J., A. Hever, D. Willhite, A. Zlotnik, and P. Hevezi. 2005. Effects of RNA degradation on gene expression analysis of human postmortem tissues. FASEB J. 19: 1356-1358. (Pubitemid 41113748)
12. Hromas, R., H. E. Broxmeyer, C. Kim, H. Nakshatri, K. Christopherson, II, M. Azam, and Y. H. Hou. 1999. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem. Biophys. Res. Commun. 255: 703-706. (Pubitemid 29294862)
13. Maerki, C., S. Meuter, M. Liebi, K. Mühlemann, M. J. Frederick, N. Yawalkar, B. Moser, and M. Wolf. 2009. Potent and broad-spectrum antimicrobial activity of CXCL14 suggests an immediate role in skin infections. J. Immunol. 182: 507-514.
14. Shellenberger, T. D., M. Wang, M. Gujrati, A. Jayakumar, R. M. Strieter, M. D. Burdick, C. G. Ioannides, C. L. Efferson, A. K. El-Naggar, D. Roberts, et al. 2004. BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res. 64: 8262-8270. (Pubitemid 39496830)
15. Meuter, S., and B. Moser. 2008. Constitutive expression of CXCL14 in healthy human and murine epithelial tissues. Cytokine 44: 248-255.
16. Pisabarro, M. T., B. Leung, M. Kwong, R. Corpuz, G. D. Frantz, N. Chiang, R. Vandlen, L. J. Diehl, N. Skelton, H. S. Kim, et al. 2006. Cutting edge: novel human dendritic cell- and monocyte-attracting chemokine-like protein identified by fold recognition methods. J. Immunol. 176: 2069-2073. (Pubitemid 43201652)
17. Wang, W., H. Soto, E. R. Oldham, M. E. Buchanan, B. Homey, D. Catron, N. Jenkins, N. G. Copeland, D. J. Gilbert, N. Nguyen, et al. 2000. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J. Biol. Chem. 275: 22313-22323. (Pubitemid 30621816)
18. Liu, B., and E. Wilson. 2010. The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids. Eur. J. Immunol. 40: 186-196.
19. Frick, I. M., S. L. Nordin, M. Baumgarten, M. Mörgelin, O. E. Sørensen, A. I. Olin, and A. Egesten. 2011. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes. J. Immunol. 187: 4300-4309.
20. Raghu, G., H. R. Collard, J. J. Egan, F. J. Martinez, J. Behr, K. K. Brown, T. V. Colby, J. F. Cordier, K. R. Flaherty, J. A. Lasky, et al ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. 2011. An official ATS/ERS/JRS/ ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183: 788-824.
21. Pardo, A., K. Gibson, J. Cisneros, T. J. Richards, Y. Yang, C. Becerril, S. Yousem, I. Herrera, V. Ruiz, M. Selman, and N. Kaminski. 2005. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2: e251.
22. Bourges, D., F. Meurens, M. Berri, C. Chevaleyre, G. Zanello, B. Levast, S. Melo, V. Gerdts, and H. Salmon. 2008. New insights into the dual recruitment of IgA+ B cells in the developing mammary gland. Mol. Immunol. 45: 3354-3362.
23. Vicari, A. P., D. J. Figueroa, J. A. Hedrick, J. S. Foster, K. P. Singh, S. Menon, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, K. B. Bacon, and A. Zlotnik. 1997. TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development. Immunity 7: 291-301. (Pubitemid 27392020)
24. Hadjicharalambous, C., T. Sheynis, R. Jelinek, M. T. Shanahan, A. J. Ouellette, and E. Gizeli. 2008. Mechanisms of alpha-defensin bactericidal action: comparative membrane disruption by Cryptdin-4 and its disulfide-null analogue. Biochemistry 47: 12626-12634.
25. Kurth, I., K. Willimann, P. Schaerli, T. Hunziker, I. Clark-Lewis, and B. Moser. 2001. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med. 194: 855-861. (Pubitemid 32983020)
26. Mastroianni, J. R., and A. J. Ouellette. 2009. Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen. J. Biol. Chem. 284: 27848-27856.
27. Masuda, K., K. Nakamura, S. Yoshioka, R. Fukaya, N. Sakai, and T. Ayabe.2011. Regulation of microbiota by antimicrobial peptides in the gut. Adv. Otorhinolaryngol. 72: 97-99.
28. Björstad, A., H. Fu, A. Karlsson, C. Dahlgren, and J. Bylund. 2005. Interleukin- 8-derived peptide has antibacterial activity. Antimicrob. Agents Chemother. 49: 3889-3895. (Pubitemid 41233046)
29. Linge, H. M., M. Collin, A. Giwercman, J. Malm, A. Bjartell, and A. Egesten. 2008. The antibacterial chemokine MIG/CXCL9 is constitutively expressed in epithelial cells of the male urogenital tract and is present in seminal plasma. J. Interferon Cytokine Res. 28: 191-196. (Pubitemid 351380152)
30. Satchell, D. P., T. Sheynis, Y. Shirafuji, S. Kolusheva, A. J. Ouellette, and R. Jelinek. 2003. Interactions of mouse Paneth cell alpha-defensins and alpha-defensin precursors with membranes. Prosegment inhibition of peptide association with biomimetic membranes. J. Biol. Chem. 278: 13838-13846. (Pubitemid 36799922)
31. Hristova, K., M. E. Selsted, and S. H. White. 1996. Interactions of monomeric rabbit neutrophil defensins with bilayers: comparison with dimeric human defensin HNP-2. Biochemistry 35: 11888-11894. (Pubitemid 26303708)
32. Figueredo, S. M., C. S. Weeks, S. K. Young, and A. J. Ouellette. 2009. Anionic amino acids near the pro-alpha-defensin N terminus mediate inhibition of bactericidal activity in mouse pro-cryptdin-4. J. Biol. Chem. 284: 6826-6831.
33. Weinstein, E. J., R. Head, D. W. Griggs, D. Sun, R. J. Evans, M. L. Swearingen, M. M. Westlin, and R. Mazzarella. 2006. VCC-1, a novel chemokine, promotes tumor growth. Biochem. Biophys. Res. Commun. 350: 74-81. (Pubitemid 44466575)
34. Mu, X., Y. Chen, S. Wang, X. Huang, H. Pan, and M. Li. 2009. Overexpression of VCC-1 gene in human hepatocellular carcinoma cells promotes cell proliferation and invasion. Acta Biochim. Biophys. Sin. (Shanghai) 41: 631-637.
35. Yang, D., Q. Chen, D. M. Hoover, P. Staley, K. D. Tucker, J. Lubkowski, and J. J. Oppenheim. 2003. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J. Leukoc. Biol. 74: 448-455. (Pubitemid 38040406)
36. Yung, S. C., D. Parenti, and P. M. Murphy. 2011. Host chemokines bind to Staphylococcus aureus and stimulate protein A release. J. Biol. Chem. 286: 5069-5077.
37. Eliasson, M., and A. Egesten. 2008. Antibacterial chemokines - actors in both innate and adaptive immunity. Contrib. Microbiol. 15: 101-117.
38. Lortat-Jacob, H., A. Grosdidier, and A. Imberty. 2002. Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl. Acad. Sci. USA 99: 1229-1234. (Pubitemid 34136475)
39. Yoshie, O., T. Imai, and H. Nomiyama. 2001. Chemokines in immunity. Adv. Immunol. 78: 57-110. (Pubitemid 32566018)
40. Hristova, K., M. E. Selsted, and S. H. White. 1997. Critical role of lipid composition in membrane permeabilization by rabbit neutrophil defensins. J. Biol. Chem. 272: 24224-24233. (Pubitemid 27418623)
41. Seibold, M. A., A. L. Wise, M. C. Speer, M. P. Steele, K. K. Brown, J. E. Loyd, T. E. Fingerlin, W. Zhang, G. Gudmundsson, S. D. Groshong, et al. 2011. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 364: 1503-1512.
42. King, T. E., Jr., A. Pardo, and M. Selman. 2011. Idiopathic pulmonary fibrosis. Lancet 378: 1949-1961.
43. Katzenstein, A. L., S. Mukhopadhyay, and J. L. Myers. 2008. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum. Pathol. 39: 1275-1294.
44. Hiraoka, N., R. Yamazaki-Itoh, Y. Ino, Y. Mizuguchi, T. Yamada, S. Hirohashi, and Y. Kanai. 2011. CXCL17 and ICAM2 are associated with a potential antitumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. Gastroenterology 140: 310-321.
45. Tsoumakidou, M., K. P. Karagiannis, I. Bouloukaki, S. Zakynthinos, N. Tzanakis, and N. M. Siafakas. 2009. Increased bronchoalveolar lavage fluid CD1c expressing dendritic cells in idiopathic pulmonary fibrosis. Respiration 78: 446-452.
46. Ebina, M., M. Shimizukawa, N. Shibata, Y. Kimura, T. Suzuki, M. Endo, H. Sasano, T. Kondo, and T. Nukiwa. 2004. Heterogeneous increase in CD34- positive alveolar capillaries in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 169: 1203-1208. (Pubitemid 38680397)
47. Selman, M., A. Pardo, L. Barrera, A. Estrada, S. R. Watson, K. Wilson, N. Aziz, N. Kaminski, and A. Zlotnik. 2006. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 173: 188-198. (Pubitemid 43187891)